Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Carleton

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Kidney360|April 26, 2024
Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in ChildrenRyan S Huang, Kelly R McMahon, Stella Wang, et al.
Critical Reviews in Oncology/Hematology|April 1, 2021
Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysisHedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, et al.
Kidney360|April 4, 2022
Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney InjuryKelly R McMahon, Hayton Chui, Shahrad Rod Rassekh, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
TLR4 downregulation protects against cisplatin-induced ototoxicity in adult and pediatric patients with cancerJohn J W Lee, Asna Latif, Erika N Scott, et al.
Pediatric Nephrology (Berlin, Germany)|June 26, 2023
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatinHayton Chui, Kelly R McMahon, Shahrad Rod Rassekh, et al.
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
Pediatric Nephrology (Berlin, Germany)|October 19, 2022
Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational studyKelly R McMahon, Asaf Lebel, Shahrad Rod Rassekh, et al.
Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of <i>ERCC1</i>, <i>ERCC2</i>, <i>SLC22A2</i> and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.
British Journal of Clinical Pharmacology|May 6, 2026
Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patientsYong Jin Lim, Amy Thachil, Kelly McMahon, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
The Pharmacogenomics Journal|November 2, 2019
CYP2C9, VKORC1, and CYP4F2 polymorphisms and pediatric warfarin maintenance dose: a systematic review and meta-analysisMasanobu Takeuchi, Tohru Kobayashi, Tina Biss, et al.
Kidney360|April 26, 2024
Tubular Injury Biomarkers to Predict CKD and Hypertension at 3 Months Post-Cisplatin in ChildrenRyan S Huang, Kelly R McMahon, Stella Wang, et al.
Critical Reviews in Oncology/Hematology|April 1, 2021
Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysisHedy Maagdenberg, Natanja Oosterom, Jolanda Zanen, et al.
Kidney360|April 4, 2022
Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney InjuryKelly R McMahon, Hayton Chui, Shahrad Rod Rassekh, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 2025
TLR4 downregulation protects against cisplatin-induced ototoxicity in adult and pediatric patients with cancerJohn J W Lee, Asna Latif, Erika N Scott, et al.
Pediatric Nephrology (Berlin, Germany)|June 26, 2023
Urinary TIMP-2*IGFBP-7 to diagnose acute kidney injury in children receiving cisplatinHayton Chui, Kelly R McMahon, Shahrad Rod Rassekh, et al.
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
Pediatric Nephrology (Berlin, Germany)|October 19, 2022
Acute kidney injury during cisplatin therapy and associations with kidney outcomes 2 to 6 months post-cisplatin in children: a multi-centre, prospective observational studyKelly R McMahon, Asaf Lebel, Shahrad Rod Rassekh, et al.
Genes|May 15, 2019
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of <i>ERCC1</i>, <i>ERCC2</i>, <i>SLC22A2</i> and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsZulfan Zazuli, Leila S Otten, Britt I Drögemöller, et al.
British Journal of Clinical Pharmacology|May 6, 2026
Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patientsYong Jin Lim, Amy Thachil, Kelly McMahon, et al.
Pageof 14